Global Anti-Viral Drugs Market Insights and Forecast to 2026

1 Study Coverage

• 1.1 Anti-Viral Drugs Product Introduction
• 1.2 Market Segments
• 1.3 Key Anti-Viral Drugs Manufacturers Covered: Ranking by Revenue
• 1.4 Market by Type
  • 1.4.1 Global Anti-Viral Drugs Market Size Growth Rate by Type
  • 1.4.2 Nucleotide Polymerase Inhibitor
  • 1.4.3 Reverse Transcriptase Inhibitor
  • 1.4.4 Protease Inhibitor
• 1.5 Market by Application
  • 1.5.1 Global Anti-Viral Drugs Market Size Growth Rate by Application
  • 1.5.2 HIV
  • 1.5.3 Hepatitis
  • 1.5.4 HSV
  • 1.5.5 Influenza
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Anti-Viral Drugs Market Size, Estimates and Forecasts
  • 2.1.1 Global Anti-Viral Drugs Revenue 2015-2026
  • 2.1.2 Global Anti-Viral Drugs Sales 2015-2026
• 2.2 Global Anti-Viral Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.2.1 Global Anti-Viral Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
  • 2.2.2 Global Anti-Viral Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Anti-Viral Drugs Competitor Landscape by Players

• 3.1 Anti-Viral Drugs Sales by Manufacturers
  • 3.1.1 Anti-Viral Drugs Sales by Manufacturers (2015-2020)
  • 3.1.2 Anti-Viral Drugs Sales Market Share by Manufacturers (2015-2020)
• 3.2 Anti-Viral Drugs Revenue by Manufacturers
  • 3.2.1 Anti-Viral Drugs Revenue by Manufacturers (2015-2020)
  • 3.2.2 Anti-Viral Drugs Revenue Share by Manufacturers (2015-2020)
  • 3.2.3 Global Anti-Viral Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
  • 3.2.4 Global Top 10 and Top 5 Companies by Anti-Viral Drugs Revenue in 2019
  • 3.2.5 Global Anti-Viral Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Anti-Viral Drugs Price by Manufacturers
• 3.4 Anti-Viral Drugs Manufacturing Base Distribution, Product Types
  • 3.4.1 Anti-Viral Drugs Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Anti-Viral Drugs Product Type
  • 3.4.3 Date of International Manufacturers Enter into Anti-Viral Drugs Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Anti-Viral Drugs Market Size by Type (2015-2020)
  • 4.1.1 Global Anti-Viral Drugs Sales by Type (2015-2020)
  • 4.1.2 Global Anti-Viral Drugs Revenue by Type (2015-2020)
  • 4.1.3 Anti-Viral Drugs Average Selling Price (ASP) by Type (2015-2026)
• 4.2 Global Anti-Viral Drugs Market Size Forecast by Type (2021-2026)
  • 4.2.1 Global Anti-Viral Drugs Sales Forecast by Type (2021-2026)
  • 4.2.2 Global Anti-Viral Drugs Revenue Forecast by Type (2021-2026)
  • 4.2.3 Anti-Viral Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
• 4.3 Global Anti-Viral Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

• 5.1 Global Anti-Viral Drugs Market Size by Application (2015-2020)
  • 5.1.1 Global Anti-Viral Drugs Sales by Application (2015-2020)
  • 5.1.2 Global Anti-Viral Drugs Revenue by Application (2015-2020)
  • 5.1.3 Anti-Viral Drugs Price by Application (2015-2020)
• 5.2 Anti-Viral Drugs Market Size Forecast by Application (2021-2026)
  • 5.2.1 Global Anti-Viral Drugs Sales Forecast by Application (2021-2026)
  • 5.2.2 Global Anti-Viral Drugs Revenue Forecast by Application (2021-2026)
  • 5.2.3 Global Anti-Viral Drugs Price Forecast by Application (2021-2026)

6 North America

• 6.1 North America Anti-Viral Drugs by Country
  • 6.1.1 North America Anti-Viral Drugs Sales by Country
  • 6.1.2 North America Anti-Viral Drugs Revenue by Country
  • 6.1.3 U.S.
  • 6.1.4 Canada
• 6.2 North America Anti-Viral Drugs Market Facts & Figures by Type
• 6.3 North America Anti-Viral Drugs Market Facts & Figures by Application

7 Europe

• 7.1 Europe Anti-Viral Drugs by Country
  • 7.1.1 Europe Anti-Viral Drugs Sales by Country
  • 7.1.2 Europe Anti-Viral Drugs Revenue by Country
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 U.K.
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Anti-Viral Drugs Market Facts & Figures by Type
• 7.3 Europe Anti-Viral Drugs Market Facts & Figures by Application

8 Asia Pacific

• 8.1 Asia Pacific Anti-Viral Drugs by Region
  • 8.1.1 Asia Pacific Anti-Viral Drugs Sales by Region
  • 8.1.2 Asia Pacific Anti-Viral Drugs Revenue by Region
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 South Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Taiwan
  • 8.1.9 Indonesia
  • 8.1.10 Thailand
  • 8.1.11 Malaysia
  • 8.1.12 Philippines
  • 8.1.13 Vietnam
• 8.2 Asia Pacific Anti-Viral Drugs Market Facts & Figures by Type
• 8.3 Asia Pacific Anti-Viral Drugs Market Facts & Figures by Application

9 Latin America

• 9.1 Latin America Anti-Viral Drugs by Country
  • 9.1.1 Latin America Anti-Viral Drugs Sales by Country
  • 9.1.2 Latin America Anti-Viral Drugs Revenue by Country
  • 9.1.3 Mexico
  • 9.1.4 Brazil
  • 9.1.5 Argentina
• 9.2 Central & South America Anti-Viral Drugs Market Facts & Figures by Type
• 9.3 Central & South America Anti-Viral Drugs Market Facts & Figures by Application

10 Middle East and Africa

• 10.1 Middle East and Africa Anti-Viral Drugs by Country
  • 10.1.1 Middle East and Africa Anti-Viral Drugs Sales by Country
  • 10.1.2 Middle East and Africa Anti-Viral Drugs Revenue by Country
  • 10.1.3 Turkey
  • 10.1.4 Saudi Arabia
  • 10.1.5 U.A.E
• 10.2 Middle East and Africa Anti-Viral Drugs Market Facts & Figures by Type
• 10.3 Middle East and Africa Anti-Viral Drugs Market Facts & Figures by Application

11 Company Profiles

• 11.1 F. Hoffmann-La Roche
  • 11.1.1 F. Hoffmann-La Roche Corporation Information
  • 11.1.2 F. Hoffmann-La Roche Description and Business Overview
  • 11.1.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
  • 11.1.4 F. Hoffmann-La Roche Anti-Viral Drugs Products Offered
  • 11.1.5 F. Hoffmann-La Roche Related Developments
• 11.2 GlaxoSmithKline
  • 11.2.1 GlaxoSmithKline Corporation Information
  • 11.2.2 GlaxoSmithKline Description and Business Overview
  • 11.2.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
  • 11.2.4 GlaxoSmithKline Anti-Viral Drugs Products Offered
  • 11.2.5 GlaxoSmithKline Related Developments
• 11.3 Bristol-Myers-Squibb
  • 11.3.1 Bristol-Myers-Squibb Corporation Information
  • 11.3.2 Bristol-Myers-Squibb Description and Business Overview
  • 11.3.3 Bristol-Myers-Squibb Sales, Revenue and Gross Margin (2015-2020)
  • 11.3.4 Bristol-Myers-Squibb Anti-Viral Drugs Products Offered
  • 11.3.5 Bristol-Myers-Squibb Related Developments
• 11.4 AbbVie
  • 11.4.1 AbbVie Corporation Information
  • 11.4.2 AbbVie Description and Business Overview
  • 11.4.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
  • 11.4.4 AbbVie Anti-Viral Drugs Products Offered
  • 11.4.5 AbbVie Related Developments
• 11.5 Johnson & Johnson
  • 11.5.1 Johnson & Johnson Corporation Information
  • 11.5.2 Johnson & Johnson Description and Business Overview
  • 11.5.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
  • 11.5.4 Johnson & Johnson Anti-Viral Drugs Products Offered
  • 11.5.5 Johnson & Johnson Related Developments
• 11.6 Merck & Co
  • 11.6.1 Merck & Co Corporation Information
  • 11.6.2 Merck & Co Description and Business Overview
  • 11.6.3 Merck & Co Sales, Revenue and Gross Margin (2015-2020)
  • 11.6.4 Merck & Co Anti-Viral Drugs Products Offered
  • 11.6.5 Merck & Co Related Developments
• 11.7 Aurobindo Pharma
  • 11.7.1 Aurobindo Pharma Corporation Information
  • 11.7.2 Aurobindo Pharma Description and Business Overview
  • 11.7.3 Aurobindo Pharma Sales, Revenue and Gross Margin (2015-2020)
  • 11.7.4 Aurobindo Pharma Anti-Viral Drugs Products Offered
  • 11.7.5 Aurobindo Pharma Related Developments
• 11.8 Cipla
  • 11.8.1 Cipla Corporation Information
  • 11.8.2 Cipla Description and Business Overview
  • 11.8.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
  • 11.8.4 Cipla Anti-Viral Drugs Products Offered
  • 11.8.5 Cipla Related Developments
• 11.9 Dr Reddy’s
  • 11.9.1 Dr Reddy’s Corporation Information
  • 11.9.2 Dr Reddy’s Description and Business Overview
  • 11.9.3 Dr Reddy’s Sales, Revenue and Gross Margin (2015-2020)
  • 11.9.4 Dr Reddy’s Anti-Viral Drugs Products Offered
  • 11.9.5 Dr Reddy’s Related Developments
• 11.1 F. Hoffmann-La Roche
  • 11.1.1 F. Hoffmann-La Roche Corporation Information
  • 11.1.2 F. Hoffmann-La Roche Description and Business Overview
  • 11.1.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
  • 11.1.4 F. Hoffmann-La Roche Anti-Viral Drugs Products Offered
  • 11.1.5 F. Hoffmann-La Roche Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

• 12.1 Anti-Viral Drugs Market Estimates and Projections by Region
  • 12.1.1 Global Anti-Viral Drugs Sales Forecast by Regions 2021-2026
  • 12.1.2 Global Anti-Viral Drugs Revenue Forecast by Regions 2021-2026
• 12.2 North America Anti-Viral Drugs Market Size Forecast (2021-2026)
  • 12.2.1 North America: Anti-Viral Drugs Sales Forecast (2021-2026)
  • 12.2.2 North America: Anti-Viral Drugs Revenue Forecast (2021-2026)
  • 12.2.3 North America: Anti-Viral Drugs Market Size Forecast by Country (2021-2026)
• 12.3 Europe Anti-Viral Drugs Market Size Forecast (2021-2026)
  • 12.3.1 Europe: Anti-Viral Drugs Sales Forecast (2021-2026)
  • 12.3.2 Europe: Anti-Viral Drugs Revenue Forecast (2021-2026)
  • 12.3.3 Europe: Anti-Viral Drugs Market Size Forecast by Country (2021-2026)
• 12.4 Asia Pacific Anti-Viral Drugs Market Size Forecast (2021-2026)
  • 12.4.1 Asia Pacific: Anti-Viral Drugs Sales Forecast (2021-2026)
  • 12.4.2 Asia Pacific: Anti-Viral Drugs Revenue Forecast (2021-2026)
  • 12.4.3 Asia Pacific: Anti-Viral Drugs Market Size Forecast by Region (2021-2026)
• 12.5 Latin America Anti-Viral Drugs Market Size Forecast (2021-2026)
  • 12.5.1 Latin America: Anti-Viral Drugs Sales Forecast (2021-2026)
  • 12.5.2 Latin America: Anti-Viral Drugs Revenue Forecast (2021-2026)
  • 12.5.3 Latin America: Anti-Viral Drugs Market Size Forecast by Country (2021-2026)
• 12.6 Middle East and Africa Anti-Viral Drugs Market Size Forecast (2021-2026)
  • 12.6.1 Middle East and Africa: Anti-Viral Drugs Sales Forecast (2021-2026)
  • 12.6.2 Middle East and Africa: Anti-Viral Drugs Revenue Forecast (2021-2026)
  • 12.6.3 Middle East and Africa: Anti-Viral Drugs Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Porter's Five Forces Analysis
• 13.5 Primary Interviews with Key Anti-Viral Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Anti-Viral Drugs Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details